MedicineWatch US
Class I Recall

Mylan Pharmaceuticals Inc

Product
Insulin Glargine (Insulin glargine-yfgn) Injection, 100 units/mL (U-100), 3 mL prefilled pens (NDC 49502-394-71), packaged in cartons of 5 prefilled pens (NDC 49502-394-75), Rx only, Manufactured by: Mylan Pharmaceuticals Inc., Morgantown, WV 15317, Manufactured for: Mylan Specialty L.P., Morgantown, WV
Reason
Labeling: Missing label: Label missing from some prefilled pens.
Classification
Class I
Status
Terminated
Lot
Lot #: BF21002895, Exp. Date Aug 2023
Date
Disclaimer: This tool indexes published US FDA drug-enforcement recall records from all countries, limited to the latest five years. A company or product not appearing here is not proof that it is compliant, approved, safe, or free of FDA action.
Mylan Pharmaceuticals Inc — Class I Recall | MedicineWatch US